PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
24-Jul-2025 Kling Bio Announces Collaboration with Sanofi for Accelerated Discovery of Neutralizing Antibodies Kling Bio
24-Jul-2025 MIG Capital leads CHF 7.75 million seed financing for ASTRA Therapeutics ASTRA Therapeutics
24-Jul-2025 Kling Bio Announces Collaboration with Sanofi for Accelerated Discovery of Neutralizing Antibodies Kling Bio
22-Jul-2025 Logical Biological Launches Sister Company, Logical Antigen, Delivering Customised Antigen and Protein Purification for IVD Market Logical Biological
22-Jul-2025 Neuraxpharm continues international expansion with launch of Neuraxpharm Australia Neuraxpharm Group
22-Jul-2025 Sanofi to acquire next-generation vaccine biotech Vicebio for US$1.6 billion Sanofi, Vicebio
21-Jul-2025 CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets China Medical System Holdings Limited
21-Jul-2025 Corteria Pharmaceuticals initiates Phase 2 trial in heart failure and Phase 1 trial in obesity with its first-in-class CRF2 agonists Andrew Lloyd Associates
18-Jul-2025 EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) ARS Pharmaceuticals, Inc.
17-Jul-2025 One Biosciences Announces €15 Million Series A Financing to Advance Clinical Single Cell Profiling One Biosciences
17-Jul-2025 US FDA approves GSK’s Shingrix in a prefilled syringe presentation GSK
16-Jul-2025 £1m Funding for Innovative Drug Discovery Projects in Collaboration with Medicines Discovery Catapult Medicines Discovery Catapult
16-Jul-2025 Yourgene Health Launches LightBench Discover Yourgene Health
15-Jul-2025 Vertex Announces Broad Reimbursement Agreement with NHS England for ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor) an Innovative Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis Vertex Pharmaceuticals
14-Jul-2025 Avascular Necrosis Market to Reach USD 1.13 Billion by 2033, Fuelled by Advances in Regenerative Therapies and Orthopedic Innovation Ameco Research
11-Jul-2025 Platelet Rich Plasma Market Expected to Reach USD 2,018.1 Million by 2033, Driven by Regenerative Medicine and Aesthetic Demand - Exclusive By Ameco Research Ameco Research
11-Jul-2025 Alfa Chemistry Unveils an Array of Premium Titanium Dioxide Products Alfa Chemistry
11-Jul-2025 Alfa Chemistry Expands Portfolio by Offering Methoxytriethyleneoxypropyltrimethoxysilane for Diverse Applications Alfa Chemistry
10-Jul-2025 VIVES Partners joins Nuclidium AG’s €84M Series B financing  Andrew Lloyd Associates
09-Jul-2025 Neuraxpharm and Dizlin Pharmaceuticals Announce Global Strategic Co-Development Agreement Bringing Next-Generation Drug-Device Therapy to Patients with Advanced Parkinson’s Disease Neuraxpharm